Manning & Napier Group, LLC Astrazeneca PLC Transaction History
Manning & Napier Group, LLC
- $8.76 Billion
- Q1 2024
A detailed history of Manning & Napier Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Manning & Napier Group, LLC holds 2,811,069 shares of AZN stock, worth $189 Million. This represents 2.17% of its overall portfolio holdings.
Number of Shares
2,811,069
Previous 2,779,212
1.15%
Holding current value
$189 Million
Previous $187 Million
1.75%
% of portfolio
2.17%
Previous 2.23%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.23 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.82 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...